A recent systematic review examining the role of TLE1 as a diagnostic biomarker for SS found that the mean sensitivity and specificity of TLE1 in detecting SS were 94 and 81%, respectively (3, 21). This evidence concerns the gene TLE1 and synovial sarcoma.